ESALY Projected Dividend Yield
ADR (Sponsored)/Eisai Co., Ltd. ( OTCBB : ESALY )Eisai is mainly engaged in the research, development, manufacture and sale of pharmaceutical products. Co.'s principal prescription drugs include anticancer agents, anti-Alzheimer's agent, anti-TNF monoclonal antibodies, antiepileptic agents, proton pump inhibitors, neuropathic pain relievers, and other prescription drugs under the name of Halaven®, Lenvima®, Fycompa® and Dayvigo®. Co.'s principal over-the-counter products include Vitamin B2 preparations "Chocola BB," gastrointestinal drugs, anti-allergic drugs and dermatological preparations. Co. operates its business activities in Japan, North America, China, Europe, Middle East, Africa, Oceania, Asia and Latin America. 31 YEAR PERFORMANCE RESULTS |
ESALY Dividend History Detail ESALY Dividend News ESALY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2022 |
N/A |
N/A |
Sep 29, 2022 |
Nov 28, 2022 |
0.5702 |
2022 |
N/A |
N/A |
Mar 30, 2022 |
Jun 01, 2022 |
0.6280 |
2022 Total: |
1.1982 |
||||
2021 |
N/A |
N/A |
Sep 29, 2021 |
Nov 29, 2021 |
0.6981 |
2021 |
N/A |
N/A |
Mar 30, 2021 |
May 28, 2021 |
0.7332 |
2021 Total: |
1.4313 |
||||
2020 |
N/A |
N/A |
Sep 29, 2020 |
Nov 27, 2020 |
0.7686 |
2020 |
N/A |
N/A |
Mar 30, 2020 |
Jun 01, 2020 |
0.7429 |
2020 Total: |
1.5115 |
||||
2019 |
N/A |
N/A |
Sep 27, 2019 |
Nov 26, 2019 |
0.7358 |
2019 |
N/A |
N/A |
Mar 28, 2019 |
May 30, 2019 |
0.7242 |
2019 Total: |
1.4601 |